Survival analysis of both Fudan and TCGA HBV-HCC datasets indicated that patients with higher mRNA and protein levels of ALKBH5 had markedly less total survival rate than patients with lower ALKBH5 expression (Fig. 2E and F). The gene discussed is ALKBH5; the disease is hepatocellular carcinoma.